These newer treatments , including Semaglutide , belong to a group of drugs called GLP-1 receptor agonists . Initially intended for managing type 2 diabetes , they work by assisting the body to produce more insulin production and reducing excessive glucose levels. Furthermore , their capacity to encourage weight loss has resulted to significant att